Abstract Background: Microscopic polyangiitis (MPA) remains associated with substantial early mortality despite advances in immunosuppressive therapy, highlighting the need for simple biomarkers that facilitate LR) has been associated with disease activity and prognosis in antineutrophil cytoplasmic antibody-associated vasculitis (AAV), its phenotype-specific significance in newly diagnosed MPA remains unclear.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Ryu Watanabe
Immunogenicity and safety of recombinant zoster vaccine in Japanese patients with RA receiving upadacitinib: the end Zoster-J study
Abstract Patients with rheumatoid arthritis (RA) treated with Janus kinase (JAK) inhibitors are at increased risk of herpes zoster (HZ). Although the adjuvanted recombinant zoster vaccine (RZV) is recommended, its immunogenicity and safety under JAK inhibitor therapy remain incompletely characterized. We evaluated humoral and cellular immune responses and safety of RZV in Japanese patients with RA receiving methotrexate (MTX), upadacitinib (UPA), or their combination.
Comparative Insights on IL-5 Targeting with Mepolizumab and Benralizumab: Enhancing EGPA Treatment Strategies
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Rheumatoid Factor: Diagnostic and Prognostic Performance and Therapeutic Implications in Rheumatoid Arthritis
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Immune Response to an Adjuvanted Recombinant Zoster Vaccine in Japanese Patients with Rheumatoid Arthritis Receiving Upadacitinib (End Zoster-J Study): Study Protocol for an Exploratory Parallel Triple-Arm Prospective Trial
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Bridging Gaps and Charting Future Directions in Vasculitis
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort | Arthritis Research & Therapy | Full Text
Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320(13):1360–72. Article PubMed Google Scholar Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001. Article PubMed Google Scholar Kim HS, Lee S, Kim JH. Real-world evidence versus randomized controlled trial: clinical research based on electronic medical records. J Korean Med Sci. 2018;33(34):e213.
Risk prediction model for mortality in microscopic polyangiitis: multicentre REVEAL cohort study - Arthritis Research & Therapy
This retrospective multicentre observational study was conducted using the Registry of Vasculitis Patients to Establish the REAL World Evidence (REVEAL) cohort to elucidate the prognostic factors associated with mortality and develop a predictive model for mortality in patients with MPA. The REVEAL cohort encompasses a multicentre observational registry of patients with MPA within the Kansai District of Japan.
Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations
1. Introduction Eosinophilic granulomatosis with polyangiitis (EGPA) is a necrotizing vasculitis that affects small- and medium-sized blood vessels [1]. EGPA is histopathologically characterized by extensive infiltration of eosinophils and causes organ damage due to tissue inflammation and ischemia [2]. EGPA was first reported by Churg and Strauss in 1951 [3] and is now recognized as an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis [4].
Frontiers | Vasculitis distribution and clinical characteristics in giant cell arteritis: a retrospective study using the new 2022 ACR/EULAR classification criteria
Introduction Giant cell arteritis (GCA) is the most common form of large-vessel vasculitis in the elderly population (1). If left untreated, it poses a medical emergency due to impending vision loss and stroke risk (2). In certain subpopulations, GCA has also been associated with increased mortality (3, 4). GCA predominates in women and populations of northern European descent (5).
Correspondence on ‘The use of tocilizumab and tofacitinib in patients with resolved hepatitis B infection: a case series’
Contributors RW wrote the manuscript. MH and AM revised and finalised the manuscript. Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Frontiers | Monocyte-to-high-density lipoprotein ratio as a predictor for patients with Takayasu arteritis and coronary involvement: a double-center, observational study
1 Introduction Takayasu arteritis (TAK) is a systemic vasculitis with an unknown etiology, which primarily affects the aorta and its major branches, including coronary arteries (1). Over the last decade, its prevalence was reported to be 8.4–108.3 per million in different parts of the world (2). Although this disease is rare, it is more prevalent in young Asian women (3). Coronary involvement can affect more than half of patients with TAK, causing increased mortality (4).
Clinical experience and safety of Janus kinase inhibitors in giant cell arteritis: a retrospective case series from Sweden
Per Eriksson1, Oliver Skoglund1, Cecilia Hemgren2 and Christopher Sjöwall1* 1Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection/Rheumatology, Linköping University, Linköping, Sweden 2Department of Internal Medicine, Division of Rheumatology, County Hospital Ryhov, Jönköping, Sweden The Janus kinase (JAK)–STAT signaling pathway is relevant in both Takayasu and giant cell arteritis (GCA), and the use of JAK inhibitors (JAKi) in arthritis, psoriasis, and...
Frontiers | Changes in the molecular profiles of large-vessel vasculitis treated with biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors
Kotaro Matsumoto*†, Katsuya Suzuki, Masaru Takeshita, Tsutomu Takeuchi and Yuko Kaneko Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan Giant cell arteritis and Takayasu arteritis are two types of primary large-vessel vasculitis (LVV). Although glucocorticoids (GC) are the standard treatment for LVV, the disease relapse rates are high.
CD8+ Regulatory T Cell Deficiency in Elderly-Onset Rheumatoid Arthritis
Altmetric share Share announcement Help format_quote Cite thumb_up ... Endorse textsms ... Comment Need Help? Support Find support for a specific problem in the support section of our website. Get Support Feedback Please let us know what you think of our products and services. Give Feedback Information Visit our dedicated information section to learn more about MDPI.
Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors—A 2023 Update
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessReview by Quang Minh Dang 1,†, Ryu Watanabe 1,*,†, Mayu Shiomi 1, Kazuo Fukumoto 1, Tomomi W.
Men's Tennis Topped By Illinois Wesleyan
THE BASICS Score: Illinois Wesleyan 7, Emerson 2 Location: Orlando, Fla. Date: March 14, 2023 The Lead: The Emerson men's tennis team slipped to Illinois Wesleyan, 7-2, on Tuesday afternoon in their third day of spring break action. Sophomores Ryu Watanabe and Pete Sevikul tallied points for the Lions in the No. 1 and No. 2 singles.
Elucidation of disease mechanisms underlying rheumatic immune-related adverse events may lead to novel therapeutic strategies for autoimmune diseases
http://orcid.org/0000-0002-1089-5296Ryu Watanabe1,2, Motomu Hashimoto1,2 1 Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan 2 Department of Advanced Medicine for Rheumatic Disease, Kyoto University Graduate School of Medicine, Kyoto, Japan Correspondence to Dr Ryu Watanabe, Department of Rheumatology, Osaki Citizen Hospital, Osaki 989-6136, Japan; ryuwatanabe{at}kuhp.kyoto-u.ac.jp Statistics from Altmetric.com Request Permissions...
Men's Tennis Topped By MIT
THE BASICS Score: MIT 9, Emerson 0 Location: Cambridge, Mass. (duPont Tennis Courts) Date: April 20, 2022 The Lead: The Emerson men's tennis team was bested over at MIT, 9-0, on Wednesday night a NEWMAC clash at the duPont Tennis Courts. MATCH NOTES On Wednesday night, the Emerson men's tennis team were bested in their NEWMAC clash over at MIT, 9-0.
Men's Tennis Upended At Coast Guard
THE BASICS Score: Coast Guard 9, Emerson 0 Location: New London, Conn. Date: April 13, 2022 The Lead: The Emerson men's tennis team was upended in their NEWMAC clash down at Coast Guard, 9-0, on Wednesday afternoon. DOUBLES RESULTS No. 1: Maximo Lawlor/Pete Sevikul were defeated by Myles Decoste/Sean Dreher, 8-3 No. 2: Ryu Watanabe/Daniel Kennedy were defeated by Lucas Arora/Charles Norman, 8-4 No. 3: Paul Choi/Banks Evans won by default.
Men's Tennis Slips To Babson
THE BASICS Score: Babson 9, Emerson 0 Records: Emerson Lions (4-11, 1-2 NEWMAC) ; Babson Beavers (9-3, 2-0 NEWMAC) Location: Babson Park, Mass. (Babson Tennis Courts) Date: April 10, 2022 The Lead: The Emerson men's tennis team were handed their second NEWMAC setback of the 2022 season out of Babson on Sunday afternoon by the score of 9-0. MATCH NOTES In the Lions' third NEWMAC matchup of the 2022 season out at Babson, they were unable to pick up a point and fell to the Beavers, 9-0.
Men's Tennis Upended By Rochester (N.Y.)
Posted: Mar 20, 2022 THE BASICS Score: Rochester (NY) 9, Emerson 0 Records: Emerson Lions (3-9) ; Rochester (N.Y.) Yellowjackets (3-4) Location: Walpole, Mass. (Wimbledon 109 Club) Date: March 20, 2022 The Lead: The Emerson men's tennis team were upended in their home opener, 9-0, to the Rochester (N.Y.) Yellowjackets on Sunday afternoon. MATCH NOTES The Lions were upended in all three of their doubles matches and fell in each of their singles matches on Sunday afternoon to the Yellowjackets.
Men's Tennis Picks Up Victory Over Mass.-Boston, 7-2
Posted: Mar 18, 2022 THE BASICS Score: Emerson 7, Mass.-Boston 2 Records: Emerson Lions (3-7) ; Mass.-Boston Beacons (1-3) Location: Boston, Mass. (BC High Tennis Courts) Date: March 18, 2022 The Lead: The Emerson men's tennis team made their way back into the win column with a 7-2 victory over Mass.-Boston on Friday afternoon. The Lions swept all three doubles matches and earned four singles victories.
Men's Tennis Falls To Rensselaer
Posted: Mar 11, 2022 THE BASICS Score: Rensselaer 9, Emerson 0 Records: Emerson Lions (2-8) ; Rensselaer Engineers (4-2) Location: Orlando, Fla. Date: March 11, 2022 The Lead: The Emerson men's tennis team wrapped up its spring break trip with a 9-0 shutout setback to Rensselaer on Friday afternoon. MATCH NOTES Emerson was swept in both the doubles and singles matches and were topped by the Rensselaer Engineers, 9-0. With the loss, the Lions fall to 2-8.
JAK inhibitors as promising agents for refractory Takayasu arteritis
JAK inhibitors as promising agents for refractory Takayasu arteritis http://orcid.org/0000-0002-1089-5296Ryu Watanabe Department of Rheumatology, Osaki Citizen Hospital, Osaki, Japan Correspondence to Dr Ryu Watanabe, Department of Rheumatology, Osaki Citizen Hospital, Osaki, Japan; doctorwatanaberyu{at}yahoo.co.jp Statistics from Altmetric.com systemic vasculitis therapeutics autoimmune diseases I read with great interest the article ‘Successful remission with tofacitinib in a patient with...
Men's Tennis Captures Win Over Manhattanville, 5-4
THE BASICS Score: Emerson 5, Manhattanville 4 Records: Emerson Lions (2-7) ; Manhattanville Valiants (1-2) Location: Orlando, Fla. Date: March 10, 2022 The Lead: With two doubles victories and three wins in the singles matches, the Emerson men's tennis team was able to hold off Manhattanville, 5-4, on Thursday afternoon in Orlando, Fla.
Men's Tennis Falls To Endicott
THE BASICS Score: Endicott 8, Emerson 1 Records: Emerson Lions (0-6) ; Endicott Hawks Location: Beverly, Mass. (Bass River Tennis Club) Date: February 21, 2022 The Lead: The Emerson men's tennis team picked up a doubles victory, but it was the lone victory for the Lions as the Purple & Gold slipped to Endicott, 8-1, on Monday afternoon at the Bass River Tennis Club.
Correspondence on ‘The use of tocilizumab and tofacitinib in patients with resolved hepatitis B infection: a case series’
Correspondence on ‘The use of tocilizumab and tofacitinib in patients with resolved hepatitis B infection: a case series’ Free http://orcid.org/0000-0002-1089-5296Ryu Watanabe1, Motomu Hashimoto1, Akio Morinobu2 1Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan 2Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan Correspondence to Dr Ryu Watanabe, Department of Advanced...
Elucidation of disease mechanisms underlying rheumatic immune-related adverse events may lead to novel therapeutic strategies for autoimmune diseases
Elucidation of disease mechanisms underlying rheumatic immune-related adverse events may lead to novel therapeutic strategies for autoimmune diseases Free http://orcid.org/0000-0002-1089-5296Ryu Watanabe1,2, Motomu Hashimoto1,2 1Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan 2Department of Advanced Medicine for Rheumatic Disease, Kyoto University Graduate School of Medicine, Kyoto, Japan Correspondence to Dr Ryu Watanabe,...
JAK inhibitors as promising agents for refractory Takayasu arteritis
JAK inhibitors as promising agents for refractory Takayasu arteritis Free Ryu Watanabe Department of Rheumatology, Osaki Citizen Hospital, Osaki, Japan Correspondence to Dr Ryu Watanabe, Department of Rheumatology, Osaki Citizen Hospital, Osaki, Japan; doctorwatanaberyu{at}yahoo.co.jp Statistics from Altmetric.com systemic vasculitis therapeutics autoimmune diseases I read with great interest the article ‘Successful remission with tofacitinib in a patient with refractory Takayasu arteritis...
Mycobacterium chimaera-induced tenosynovitis in a patient with rheumatoid arthritis
Mycobacterium chimaera-induced tenosynovitis in a patient with rheumatoid arthritis Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. Copyright information: © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions.
Challenging therapeutic goal in large vessel vasculitis
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. I read with great interest the recently published article by Kwon OC et al. in this journal [1]. They conducted a retrospective study on 74 patients with Takayasu arteritis (TAK) to test whether statins could reduce relapse rate after remission [1]. Patients who relapsed during the follow-up had lower frequencies of taking statins than those who did not.
CD28 Signaling Controls Metabolic Fitness of Pathogenic T Cells in Medium and Large Vessel Vasculitis
This work was supported by a sponsored research agreement with Bristol-Myers Squibb. This work was supported by the National Institutes of Health grants R01 AR042527, R01 HL117913, R01 AI108906, and P01 HL129941 to Dr. Weyand, and R01 AI108891, R01 AG045779, U19 AI057266, R01 AI129191, and I01 BX001669 to Dr. Goronzy. Dr. Zhang has received fellowship support from the Govenar Discovery Fund. Dr. Nadler is employed by and holds shares in Bristol-Myers Squibb.
Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation
Objectives Accelerated atherosclerotic disease typically complicates rheumatoid arthritis (RA), leading to premature cardiovascular death. Inflammatory macrophages are key effector cells in both rheumatoid synovitis and the plaques of coronary artery disease (CAD). Whether both diseases share macrophage-dependent pathogenic mechanisms is unknown. Methods Patients with RA or CAD (at least one myocardial infarction) and healthy age-matched controls were recruited into the study.
Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation
Objectives Accelerated atherosclerotic disease typically complicates rheumatoid arthritis (RA), leading to premature cardiovascular death. Inflammatory macrophages are key effector cells in both rheumatoid synovitis and the plaques of coronary artery disease (CAD). Whether both diseases share macrophage-dependent pathogenic mechanisms is unknown. Methods Patients with RA or CAD (at least one myocardial infarction) and healthy age-matched controls were recruited into the study.
Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity
Impaired anti-VZV immunity in patients with CAD. The risk of reactivating VZV and suffering from shingles attacks increases progressively with age, but is 20% to 30% higher in patients with CAD (15, 16). The immune system controls chronic VZV infection through virus-specific CD4 T cells, which release IFN-? (3).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Ryu
Contact Ryu, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack